Paper6135764
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M and 6 others. J Nucl Med, 1983. Cited by 241 papers, by iCite.
Cite this record
ConductScience Library. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. Papers, record 6135764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6135764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Iodine Radioisotopes | Major topic |
| Iodobenzenes | Major topic |
| 3-Iodobenzylguanidine | |
| Adrenal Gland Neoplasms | |
| Adrenal Glands | |
| Humans | |
| Liver | |
| Multiple Endocrine Neoplasia | |
| Pheochromocytoma | |
| Radionuclide Imaging | |
| Salivary Glands | |
| Spleen | |
| Time Factors | |
| Tissue Distribution | |
| Urinary Bladder |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 3M01 RR0042-22S1 CLR | NCRR NIH HHS | United States | M01RR004222 | PubMed | NIH RePORTER |
| 5P60 AM 20575 | NIADDK NIH HHS | United States | PubMed | PubMed | |
| R01 AM 21477 | NIADDK NIH HHS | United States | R01AM021477 | PubMed and NIH | NIH RePORTER |
| M01RR000042 | NIH | NIH RePORTER |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 241 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40785938 | Superior lesion detection with 18F-AlF-NOTA-octreotide PET/CT compared to 123I-MIBG SPECT/CT in neuroblastoma. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40785938 | PubMed |
| 40262827 | Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction. | J Nucl Med Technol | 2025 | https://conductscience.org/library/papers/40262827 | PubMed |
| 40064709 | Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders. | Eur J Nucl Med Mol Imaging | 2025 | https://conductscience.org/library/papers/40064709 | PubMed |
| 35197314 | Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine (mIBG). | Drug Metab Dispos | 2022 | https://conductscience.org/library/papers/35197314 | PubMed |
| 35055005 | Dosing Therapeutic Radiopharmaceuticals in Obese Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35055005 | PubMed |
| 30250991 | Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[18F]Fluorobenzylguanidine: Biodistribution and Radiation Dosimetry. | Mol Imaging Biol | 2019 | https://conductscience.org/library/papers/30250991 | PubMed |
| 30100938 | Current Consensus on I-131 MIBG Therapy. | Nucl Med Mol Imaging | 2018 | https://conductscience.org/library/papers/30100938 | PubMed |
| 30048149 | MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies. | Br J Radiol | 2018 | https://conductscience.org/library/papers/30048149 | PubMed |
| 29938300 | Guidelines on nuclear medicine imaging in neuroblastoma. | Eur J Nucl Med Mol Imaging | 2018 | https://conductscience.org/library/papers/29938300 | PubMed |
| 29042793 | Theranostics in nuclear medicine practice. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/29042793 | PubMed |
| 27469611 | The role of nuclear cardiac imaging in risk stratification of sudden cardiac death. | J Nucl Cardiol | 2016 | https://conductscience.org/library/papers/27469611 | PubMed |
| 26003179 | Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease. | J Neural Transm (Vienna) | 2015 | https://conductscience.org/library/papers/26003179 | PubMed |
| 25874239 | Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective. | ScientificWorldJournal | 2015 | https://conductscience.org/library/papers/25874239 | PubMed |
| 24765617 | Molecular imaging in heart failure patients. | Clin Transl Imaging | 2013 | https://conductscience.org/library/papers/24765617 | PubMed |
| 24663289 | A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging. | Eur J Nucl Med Mol Imaging | 2014 | https://conductscience.org/library/papers/24663289 | PubMed |
| 24213114 | Targeted radionuclide therapy. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24213114 | PubMed |
| 24089927 | Simultaneous 99mTc-MDP/123I-MIBG tumor imaging using SPECT-CT: phantom and constructed patient studies. | Med Phys | 2013 | https://conductscience.org/library/papers/24089927 | PubMed |
| 22124609 | Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. | Langenbecks Arch Surg | 2012 | https://conductscience.org/library/papers/22124609 | PubMed |
| 21431458 | [Clinical and imaging diagnostics of Parkinson's disease and multiple system atrophy]. | Radiologe | 2011 | https://conductscience.org/library/papers/21431458 | PubMed |
| 20975774 | Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. | Parkinsons Dis | 2010 | https://conductscience.org/library/papers/20975774 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6135764
GET https://conductscience.org/api/papers/v1/6135764/cited_by?page=2